comprehensive -WSS

comprehensive

author：hotspot 2025-09-06 20:46:24 - browse：5376

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Celiac disease study examines precisely how gluten triggers injury

WSS

Asbestos ban is immediate, but health effects will linger for decades

Involuntary treatment for addiction doesn't work

'Patient friction coefficient' can gauge a clinical trial's patient burden

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Erich Jarvis studies song birds to learn about human stuttering

Who gets to use the title 'doctor'?

Wikipedia

comprehensive

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Diabetes management: Digital health tools fall short, study says

Malaria cases in Florida and Texas: Here’s what you need to know

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Peter Hotez and the public health issue of online harassment

J&J expands global access to TB drug amid advocacy campaign

Medical leaders decry Supreme Court decision on affirmative action

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Supreme Court strikes down use of affirmative action

Testing GLP

leisure time

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Congress likely to miss an opportunity to fix drug shortages issue

Grail faces three suits alleging harassment, retaliation

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

What Kate Middleton's cancer revelation might teach the world

The new HIV moral panic

focus

hotspot

explore

hotspot